IMS Health Completes $500 Million Notes Offering, $1.0 Billion Exchange Offer & Amended Credit Facility
Cahill represented the joint book-running managers and co-managers in connection with the Rule 144A/Reg S offering of $500,000,000 aggregate principal amount of 6% Senior Notes due 2020 by IMS Health Incorporated. Cahill represented the dealer managers in connection with IMS Health’s $1,000,000,000 exchange offer and consent solicitation relating to its 12.50% senior notes due 2018.
Cahill also represented the administrative agent in the second amended and restated credit facility, comprised of a $1,790,000,000 Term B Loan, which represents an additional $500,000,000 of Term B Loans, a €765,000,000 Term B Loan, which represents an additional €200,000,000 in Term B Loans, a $175,000,000 U.S. Revolving Credit Facility, a $100,000,000 Japanese Revolving Credit Facility and a $100,000,000 Swiss/Multicurrency Revolving Credit Facility. The new facility also extended the maturity of each of the revolving credit facilities.